The postive cash flow is good.

 It would be nice to know if the Yoplait upfront payment was part of the "sales" or are we still waiting on that.

 I'm skeptical about us moving too much higher right away but there should be some reason for shorts to cover given our financial stability. 

We're at about 20X times sales at the moment. Can anybody provide a comparison to Martek or Pronova for reference?

Either way, I am waiting for updates on Yoplait/Nestle and a pharma deal.

bfw